Search
for
Sort by
Research 181–210 of 397
- Lrig1-expression confers suppressive function to CD4+ cells and is essential for averting autoimmunity via the Smad2/3/Foxp3 axis
- Immune therapies for alopecia areata: evidence and new perspectives
- Biological therapy in the treatment of melanoma
- Regulatory T cell dysfunction and immunotherapeutic breakthroughs in type 1 diabetes
- Interleukin gene polymorphisms and alopecia areata: A systematic review and meta-analysis
- The expanding impact of T-regs in the skin
- Celiac disease associated with alopecia areata: A multicenter case-control study
- Alopecia Areata and Atopic Dermatitis: Common Mechanisms and Emerging Therapeutics
- Use of oral Janus kinase inhibitors for the treatment of severe alopecia areata: narrative review and real-world experience
- Where is the data? Delayed and chronic irAE surveillance and management after cessation of ICIs: expert insights from SITC on survivorship care and the need for long-term data
- Association of JAK 1 and JAK 2 gene polymorphism with alopecia areata risk: a case–control genetic study
- Decoding Gut Microbiome Dysbiosis as a Non-Invasive Diagnostic Biomarker for Alopecia Areata
- 054 Deep Analysis of CD4+ Trm Cells in Normal and Atopic Dermatitis Human Skin
- Immune Cell-Targeting Biologics for Alopecia Areata: A New Paradigm in Precision Medicine
- Author response: scRNA+TCR-seq reveals the proportion and characteristics of dual TCR Treg cells in mouse lymphoid and non-lymphoid tissues
- 0009 Regulatory γδ T cells protect human scalp hair follicles from alopecia areata in vivo and represent potential therapeutic target
- Randomized Controlled Trial Study to Evaluate the Efficacy of Combination Therapy with Diphenylcyclopropenone and Platelet-Rich Plasmain Alopecia Areaata
- P110 Comparative efficacy of low-dose oral minoxidil, topical minoxidil, and platelet-rich plasma with topical minoxidil in androgenetic alopecia: a randomized controlled trial
- BH06 (P110) Comparative efficacy of low-dose oral minoxidil, topical minoxidil, and platelet-rich plasma with topical minoxidil in androgenetic alopecia: a randomized controlled trial
- Mendelian randomization study highlights hypothyroidism as a causal determinant of alopecia areata
- CAQ Corner: Basic concepts of transplant immunology
- Alopecia Areata in Twins With Autoimmune Thyroiditis: Personal Observations
- 397 Predictive modeling of drug response and mechanism of action in alopecia areata clinical trials
- Pathophysiology of the Behçet's Disease
- Nivolumab-Induced Alopecia Areata: A Case Report and Literature Review
- Cutaneous Toxicities of Advanced Treatment for Cutaneous Melanoma: A Prospective Study from a Single-Center Institution
- Risk of Autoimmune Skin Diseases Associated With Immune Checkpoint Inhibitors: A Pharmacovigilance Analysis Using the FAERS Database
- Update on pulse corticosteroid therapy for the management of alopecia areata
- Desarrollo de una nueva terapia para el tratamiento de lesiones ulcerosas crónicas mediante el trasplante alogénico de una subpoblación de células madre mesenquimales derivadas de cordones umbilicales humanos
- Nano-Enabled CRISPR-Cas Gene Editing for Cancer Therapeutics